Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

Qing Yue1, Yu Song1, Zi Liu1

  • 1Hebei Key Laboratory for Organ Fibrosis Research, School of Public Health, North China University of Science and Technology, Tangshan 063210, China.

Insights

The receptor for advanced glycation end products (RAGE) pathway is crucial in immune diseases. Targeting RAGE offers potential therapeutic strategies for conditions like lupus and Alzheimer's disease.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • The receptor for advanced glycation end products (RAGE) is a key mediator in inflammatory responses.
  • RAGE ligands include advanced glycation end products (AGEs), S100 proteins, and high-mobility group protein 1 (HMGB1).
  • RAGE signaling is implicated in various immune-related diseases such as systemic lupus erythematosus, rheumatoid arthritis, and Alzheimer's disease.

Purpose of the Study:

  • To systematically analyze RAGE-related signaling pathways and their regulatory mechanisms in immune-related diseases.
  • To explore the therapeutic potential of targeting RAGE signaling pathways.

Main Methods:

  • Review and synthesis of existing literature on RAGE signaling.
  • Analysis of RAGE's role in the pathogenesis of immune-related diseases.
  • Examination of RAGE's involvement in cellular processes like inflammation, apoptosis, autophagy, and endoplasmic reticulum stress.

Main Results:

  • RAGE activation initiates intracellular cascades, affecting signal transduction and cytokine release.
  • RAGE signaling pathways are integral to the development and progression of multiple immune-related diseases.
  • Intervention in RAGE pathways demonstrates significant therapeutic promise.

Conclusions:

  • Targeting RAGE signaling pathways presents a viable therapeutic strategy for RAGE-mediated diseases.
  • Understanding RAGE's regulatory mechanisms provides theoretical basis for future drug development.
  • Further research into RAGE pathways can lead to novel treatments for inflammatory and immune disorders.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.7K